Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins

Eric K Johnson1, Liwen Zhang, Marvin E Adams

  • 1Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, and the Ohio State University Biochemistry Program, Columbus, Ohio, United States of America.

Plos One
|September 1, 2012
PubMed

Insights

Dystrophin mutations cause muscle and heart disease. This study reveals unique protein interactions of dystrophin in heart versus skeletal muscle, identifying new cardiac-specific functions and potential disease triggers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Muscle Physiology

Background:

  • Mutations in dystrophin lead to progressive muscle and heart dysfunction, causing early mortality.
  • Disease severity and onset in cardiac and skeletal muscles are uncorrelated, suggesting distinct dystrophin roles.
  • Dystrophin's function as a scaffold implies tissue-specific protein interactions dictate its roles.

Purpose of the Study:

  • To compare the interactome of dystrophin between cardiac and skeletal muscles.
  • To identify tissue-specific protein associations of dystrophin.
  • To uncover novel cardiac-specific dystrophin interactions relevant to cardiac disease.

Main Methods:

  • Optimized a proteomics-based approach for dystrophin purification and interactome analysis.
  • Compared dystrophin protein associations in cardiac and skeletal muscle tissues.
  • Utilized small starting material quantities (as little as 50 mg).

Main Results:

  • Identified selective, tissue-specific differences in dystrophin associations with syntrophins and dystrobrevins.
  • Found novel cardiac-specific interactions of dystrophin with proteins regulating cardiac contraction.
  • Discovered interactions with proteins implicated in cardiac disease pathogenesis.

Conclusions:

  • Dystrophin exhibits distinct protein interactions and functions in cardiac versus skeletal muscle.
  • The developed proteomics approach efficiently identifies dystrophin-interacting proteins.
  • Findings may elucidate early cardiac disease triggers in muscular dystrophies and guide therapeutic strategies.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...